{
  "documentMetadata": {
    "title": "Sinusitis, Rhinosinusitis, Acute",
    "sourceFile": "Sinusitis, Rhinosinusitis, Acute.pdf",
    "lastUpdated": "2025-04-22"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Rhinosinusitis, acute, empiric therapy. \"Rhinosinusitis\" preferred over \"sinusitis\" as both sites are inflamed.",
        "Antibiotics rarely needed as etiology is most often viral:",
        "Acute viral rhinosinusitis usually resolves within 7-10 days",
        "Bacterial sinusitis occurs in only 0.5 to 2%",
        "General ref.: N Engl J Med 2016; 375:962",
        "Acute rhinosinusitis is usually a result of obstruction of sinus ostia from inflammation caused by viral infection or allergens.",
        "Treatment is oral fluids and perhaps nasal sterile saline irrigations.",
        "For discussion of the role of antibiotics in patients with persistent upper respiratory tract symptoms, see Ann Intern Med 2017,166:201.",
        "Clinical features are, at best, suggestive:",
        "Common features whether etiology is allergic, viral or bacterial:",
        "Facial pressure and frontal headaches",
        "Anosmia, nasal congestion, and postnasal drip",
        "More common in allergic sinusitis: chronic clear discharge, afebrile, sneezing, itchy eyes",
        "More common in viral sinusitis: gradual improvement over 7-10 days. May be febrile.",
        "More common features of a true bacterial sinusitis:",
        "Fever and symptom duration of more than 10 days",
        "Maxillary toothache",
        "Initial symptom improvement and then worsening of symptoms",
        "Cacosmia (sense of bad odor in the nose)",
        "Unilateral facial pain",
        "Rarely able to make a bacterial microbiologic diagnosis. Treatment regimens are empiric and focus on pathogens most often found in sinus puncture studies: S. pneumoniae, H.influenzae, Moraxella catarrhalis"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Sinus puncture results in adult patients with clinical picture of acute bacterial rhinosinusitis:",
        "Strep. pneumoniae (33%)",
        "H. influenzae (32%)",
        "M. catarrhalis (9%)",
        "Streptococcus sp. (Group A) (2%)",
        "Anaerobes (6%)",
        "Staph. aureus (10%)",
        "Viral (15%)"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "list",
      "items": [
        "Most often viral infection and management focus is symptom relief (see Comments)",
        "Guidelines indicate antibiotic therapy indicated in one of 3 situations:",
        "If at initial evaluation: fever (39 C or higher in children), intense facial pain, and purulent nasal discharge, syndrome justifies empiric treatment as bacterial rhino- sinusitis.",
        "If despite withholding antibiotics, patient is still symptomatic after 7 days, treat as bacterial sinusitis.",
        "If treated as bacterial sinusitis, patient fails therapy, see Sinusitis, Treatment Failure."
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Pediatric:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Pediatric"
            },
            "components": [
              {
                "drug": "Amoxicillin",
                "dose": "90 mg/kg/day",
                "route": "po",
                "frequency": "divided q12h"
              }
            ],
            "notes": "max. dose is 2 gm per dose"
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Pediatric"
            },
            "components": [
              {
                "drug": "Amoxicillin-clavulanate",
                "dose": "90 mg/kg/day",
                "route": "po",
                "frequency": "divided q12h"
              }
            ],
            "notes": "(extra strength) suspension, (Amox component), Max. dose of amoxicillin component is 2 gm per dose"
          }
        },
        {
          "type": "list",
          "items": [
            "Treat for 5-7 days",
            "Reference, AAP Guidelines: Pediatrics 2013; 132:e262."
          ]
        },
        {
          "type": "paragraph",
          "text": "Adult:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult"
            },
            "components": [
              {
                "drug": "Amoxicillin-clavulanate",
                "dose": "875/125 mg",
                "route": "po",
                "frequency": "bid x 5-7 days."
              }
            ],
            "notes": "Note: Higher dose of amoxicillin and extended release formulation increases amoxicillin AUC and thereby increases odds of efficacy vs common bacterial pathogens (Drugs 2005;65:121; Clin Lab Med 2004;24:503)."
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult"
            },
            "components": [
              {
                "drug": "Amoxicillin",
                "dose": "500 mg tid or 875 mg bid",
                "route": "po"
              }
            ],
            "notes": "active vs most S. pneumoniae but less desirable due to frequent resistance of beta-lactamase producing H.influenzae and M. catarrhalis"
          }
        },
        {
          "type": "list",
          "items": [
            "For Guidelines, symptomatic relief therapy, and references, see Comments section below."
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "For symptom relief therapies, see Comments"
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Pediatric patient allergic to penicillin:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Age > 6 mo and wt < 50 kg"
            },
            "components": [
              {
                "drug": "Levofloxacin",
                "dose": "16 mg/kg/day",
                "frequency": "divided q12h to max of 250 mg daily"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Wt > 50 kg"
            },
            "components": [
              {
                "drug": "Levofloxacin",
                "dose": "500 mg",
                "route": "po",
                "frequency": "q24h"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Pediatric patient allergic to penicillin"
            },
            "components": [
              {
                "drug": "Cefuroxime axetil",
                "dose": "30 mg/kg/day",
                "route": "po",
                "frequency": "divided q12h"
              }
            ],
            "notes": "Note: Cefuroxime susp not available in the US, may be available in other markets."
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Pediatric patient allergic to penicillin"
            },
            "components": [
              {
                "drug": "Cefdinir",
                "dose": "14 mg/kg/day",
                "route": "po",
                "frequency": "divided q12-24h, max of 600 mg/day"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Pediatric patient allergic to penicillin"
            },
            "components": [
              {
                "drug": "Cefpodoxime",
                "dose": "10 mg/kg/day",
                "route": "po",
                "frequency": "divided q12h"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Type 1 allergy (IgE-mediated anaphylaxis, hives)"
            },
            "components": [
              {
                "drug": "Clindamycin",
                "dose": "30-40 mg/kg/day",
                "route": "po",
                "frequency": "divided tid or qid x 10-14 days"
              }
            ],
            "notes": "is the first choice with the understanding that Haemophilus sp. and Moraxella are resistant."
          }
        },
        {
          "type": "list",
          "items": [
            "If Clindamycin use is not possible or not desired:",
            "Non-type 1 allergy (skin rash): 2nd or 3rd generation cephalosporin:",
            "Treat for 10-14 days"
          ]
        },
        {
          "type": "paragraph",
          "text": "Adult patient with Penicillin allergy:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Type 1 allergy (e.g., anaphylaxis)"
            },
            "components": [
              {
                "drug": "Levofloxacin",
                "dose": "750 mg",
                "route": "po",
                "frequency": "once daily",
                "connector": "or"
              },
              {
                "drug": "Moxifloxacin",
                "dose": "400 mg",
                "route": "po",
                "frequency": "once daily"
              }
            ],
            "durationDetail": {
              "fixedDuration": "5-7 days"
            }
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Type 1 allergy (e.g., anaphylaxis)"
            },
            "components": [
              {
                "drug": "Doxycycline",
                "dose": "100 mg",
                "route": "po",
                "frequency": "bid"
              }
            ],
            "durationDetail": {
              "fixedDuration": "5-7 days"
            }
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Type 2 allergy (e.g., skin rash)"
            },
            "components": [
              {
                "drug": "Cefdinir",
                "dose": "600 mg/day",
                "frequency": "divided q12h or q24h"
              }
            ],
            "durationDetail": {
              "fixedDuration": "5-7 days"
            }
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Type 2 allergy (e.g., skin rash)"
            },
            "components": [
              {
                "drug": "Cefpodoxime",
                "dose": "200 mg",
                "route": "po",
                "frequency": "q12h"
              }
            ],
            "durationDetail": {
              "fixedDuration": "5-7 days"
            }
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Type 2 allergy (e.g., skin rash)"
            },
            "components": [
              {
                "drug": "Cefuroxime axetil",
                "dose": "500 mg",
                "route": "po",
                "frequency": "q12h"
              }
            ],
            "durationDetail": {
              "fixedDuration": "5-7 days"
            }
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Duration of antibiotic therapy: generally 5-7 days, but see specific regimens above.",
        "Sinus symptoms are common with viral infections and allergies and are a common cause of overuse of antibiotics.",
        "Randomized trial of amoxicillin clavulonate vs placebo in children meeting criteria for treatment showed only modest benefit of treatment: 2 point difference in 40 point symptom score and 2 days faster time to total symptom resolution (7 vs 9 days). Presence of colored nasal secretions did not predict response to antibiotics. JAMA.330(4):349,2023"
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Antibiotic treatment goals:"
        },
        {
          "type": "list",
          "items": [
            "Waiting to initiate therapy is justified by the high rate of spontaneous resolution.",
            "Meta-analysis of 9 double-blind trials found no clinical signs/symptoms that justify treatment-even after 7-10 days of symptoms, Lancet 371:908, 2008.",
            "In randomized placebo-controlled trial in adults, a 10-day course of Amoxicillin compared to placebo did not reduce symptoms at day 3 of therapy, JAMA 307:685, 2012.",
            "Prevent bacterial complications, e.g., subdural empyema, epidural abscess, brain abscess, meningitis and cavernous sinus thrombosis",
            "Avoidance of chronic sinus disease",
            "Avoidance of unnecessary antibiotic use.",
            "See Ann Intern Med 2017,166:201 for discussion of role of antibiotics in patients with persistent upper respiratory tract symptoms."
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Due to increasing resistance of S. pneumoniae, avoid Macrolides (azithromycin, clarithromycin, and erythromycin) and monotherapy with 2nd and 3rd generation cephalosporins.",
        "Due to resistance of both S. pneumoniae and H. influenzae, avoid TMP-SMX.",
        "Clindamycin alone is not suggested due to lack of activity against Haemophilus sp. and Moraxella sp.",
        "American Academy of Pediatrics (AAP) guidelines considers Amoxicillin (if no daycare attendance or antibiotics in last 30 days) or Amox-Clav for first-line therapy. IDSA guidelines suggest Amox-Clav as first-line for children and adults. AAP suggests that use of fluoroquinolones in children should continue to be limited to treatment of infections for which no safe and effective alternative exists.",
        "Symptom relief (adjunct) therapies:",
        "Topical decongestant (oxymetazoline) is not generally recommended. If used, use for < 3 days.",
        "Nasal steroid: no clear evidence of benefit unless concomitant allergy.",
        "Antihistamines: minor role unless definite underlying allergic rhinitis.",
        "Saline irrigation: may help. Use only sterile saline",
        "CT scans do not help as mucosa reported as inflamed in 87% of viral URIs; but only 2% develop bacterial rhinosinusitis.",
        "Potential Complications:",
        "From acute viral rhinosinusitis-transient hyposmia.",
        "From acute bacterial rhinosinusitis-orbital infections, meningitis, epidural abscess, brain abscess.",
        "For treatment failure: see Sinusitis, treatment failure.",
        "Reference: N Engl J Med 2016; 375:962"
      ]
    }
  ]
}
